Evans TL - Search Results

1

Definitive dose thoracic radiation therapy in oligometastatic non-small cell lung cancer: A hypothesis-generating study.

Xanthopoulos EP, Handorf E, Simone CB 2nd, Grover S, Fernandes AT, Sharma S, Corradetti MN, Evans TL, Langer CJ, Mitra N, Shah A, Apisarnthanarax S, Lin LL, Rengan R. Xanthopoulos EP, et al. Among authors: evans tl. Pract Radiat Oncol. 2015 Jul-Aug;5(4):e355-63. doi: 10.1016/j.prro.2014.11.006. Epub 2015 Jan 31. Pract Radiat Oncol. 2015. PMID: 25649540

2

Building a better therapy for stage IIIA non-small cell lung cancer.

Evans TL, Donahue DM, Mathisen DJ, Lynch TJ. Evans TL, et al. Clin Chest Med. 2002 Mar;23(1):191-207. doi: 10.1016/s0272-5231(03)00068-6. Clin Chest Med. 2002. PMID: 11901911 Review.

3

Chemotherapy in advanced non-small cell lung cancer.

Evans T. Evans T. Semin Respir Crit Care Med. 2005 Jun;26(3):304-13. doi: 10.1055/s-2005-871989. Semin Respir Crit Care Med. 2005. PMID: 16052432 Review.

4

Gefitinib in patients with advanced non-small cell lung cancer (NSCLC): the expanded access protocol experience at the University of Pennsylvania.

Veronese ML, Algazy K, Bearn L, Eaby B, Alavi J, Evans T, Stevenson JP, Shults J. Veronese ML, et al. Cancer Invest. 2005;23(4):296-302. doi: 10.1081/cnv-61528. Cancer Invest. 2005. PMID: 16100941 Clinical Trial.

5

A phase II study of gefitinib in patients with advanced thyroid cancer.

Pennell NA, Daniels GH, Haddad RI, Ross DS, Evans T, Wirth LJ, Fidias PH, Temel JS, Gurubhagavatula S, Heist RS, Clark JR, Lynch TJ. Pennell NA, et al. Thyroid. 2008 Mar;18(3):317-23. doi: 10.1089/thy.2007.0120. Thyroid. 2008. PMID: 17985985 Clinical Trial.

6

Adjuvant cisplatin and docetaxel for non-small cell lung cancer: the Hospital of the University of Pennsylvania experience.

Weiss J, Eaby B, Stevenson J, Kucharczuk J, Cooper J, Kaiser L, Shrager J, Rengan R, Langer C, Evans T. Weiss J, et al. J Thorac Oncol. 2010 May;5(5):667-72. doi: 10.1097/JTO.0b013e3181d409f9. J Thorac Oncol. 2010. PMID: 20234321 Free article.

7

Elective nodal irradiation (ENI) vs. involved field radiotherapy (IFRT) for locally advanced non-small cell lung cancer (NSCLC): A comparative analysis of toxicities and clinical outcomes.

Fernandes AT, Shen J, Finlay J, Mitra N, Evans T, Stevenson J, Langer C, Lin L, Hahn S, Glatstein E, Rengan R. Fernandes AT, et al. Radiother Oncol. 2010 May;95(2):178-84. doi: 10.1016/j.radonc.2010.02.007. Epub 2010 Mar 29. Radiother Oncol. 2010. PMID: 20356642

8

Carboplatin/pemetrexed/bevacizumab in the treatment of patients with advanced non-small-cell lung cancer: a single-institution experience.

Malhotra B, Evans T, Weiss J, Eaby B, Stonehouse-Lee S, Sherry V, Langer CJ. Malhotra B, et al. Clin Lung Cancer. 2010 May;11(3):192-7. doi: 10.3816/CLC.2010.n.025. Clin Lung Cancer. 2010. PMID: 20439196

9

Adjuvant radiotherapy for completely resected stage 2 thymoma.

Berman AT, Litzky L, Livolsi V, Singhal S, Kucharczuk JC, Cooper JD, Friedberg JR, Evans TL, Stevenson JP, Metz JM, Hahn SM, Rengan R. Berman AT, et al. Among authors: evans tl. Cancer. 2011 Aug 1;117(15):3502-8. doi: 10.1002/cncr.25851. Epub 2011 Feb 1. Cancer. 2011. PMID: 21287527 Free article.

10

The impact of extent and location of mediastinal lymph node involvement on survival in Stage III non-small cell lung cancer patients treated with definitive radiotherapy.

Fernandes AT, Mitra N, Xanthopoulos E, Evans T, Stevenson J, Langer C, Kucharczuk JC, Lin L, Rengan R. Fernandes AT, et al. Int J Radiat Oncol Biol Phys. 2012 May 1;83(1):340-7. doi: 10.1016/j.ijrobp.2011.05.070. Epub 2011 Nov 19. Int J Radiat Oncol Biol Phys. 2012. PMID: 22104359

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

101 results

Search Page

Filters